EUTHYMICS BIOSCIENCE

euthymics-bioscience-logo

Euthymics Bioscience, Inc. is a neuroscience-focused clinical-stage company developing next-generation treatments for depression. Euthymics’ initial focus is on patients who do not respond adequately to SSRIs. EB-1010 for depression is expected to improve efficacy and reduce the leading side effects associated with poor adherence to standard antidepressants including weight gain, sexual dysfunction and cognitive impairment. Euthymics is a private Delaware corporation with headquarters... in Cambridge, Massachusetts. Euthymics is developing products for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and, under a collaboration with the government, alcohol use disorder (AUD). According to the National Institutes of Health, MDD affects over 15 million American adults. According to the National Institute of Alcohol Abuse and Alcoholism (NIAAA), approximately 18 million Americans have alcohol use disorder (either alcohol dependence or alcohol abuse).

#People #Financial #Website #More

EUTHYMICS BIOSCIENCE

Social Links:

Industry:
Biotechnology Life Science Pharmaceutical

Founded:
2009-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.euthymics.com

Total Employee:
11+

Status:
Active

Contact:
617-758-0300

Email Addresses:
[email protected]

Total Funding:
38.5 M USD

Technology used in webpage:
Facebook Sharer Pinterest New Relic WhatsApp OVH Facebook Like Button Plesk Citrix NetScaler ClouDNS Kk Star Ratings



Current Advisors List

joshua-funder_image

Joshua Funder Member of the Board of Directors @ Euthymics Bioscience
Board_member

anthony-a-mckinney_image

Anthony A. McKinney Member of the Board of Directors @ Euthymics Bioscience
Board_member
2009-01-01

timothy-j-barberich_image

Timothy J. Barberich Member of the Board of Directors @ Euthymics Bioscience
Board_member
2010-01-01

frank-t-gentile_image

Frank T. Gentile Member of the Board of Directors @ Euthymics Bioscience
Board_member

paul-weiss_image

Paul Weiss Member of the Board of Directors @ Euthymics Bioscience
Board_member

Current Employees Featured

franklin-p-bymaster_image

Franklin P. Bymaster
Franklin P. Bymaster Co-Founder & Chief Scientific Officer @ Euthymics Bioscience
Co-Founder & Chief Scientific Officer
2009-01-01

tom-shea_image

Tom Shea
Tom Shea CFO @ Euthymics Bioscience
CFO

walter-piskorski_image

Walter Piskorski
Walter Piskorski COO @ Euthymics Bioscience
COO

Founder


anthony-a-mckinney_image

Anthony A. McKinney

franklin-p-bymaster_image

Franklin P. Bymaster

Investors List

gbs-ventures_image

GBS Ventures

GBS Ventures investment in Series A - Euthymics Bioscience

h-q-venture-capital_image

H&Q Venture Capital

H&Q Venture Capital investment in Series A - Euthymics Bioscience

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series A - Euthymics Bioscience

venture-investors_image

Venture Investors

Venture Investors investment in Series A - Euthymics Bioscience

hambrecht-quist-capital-management_image

Hambrecht & Quist Capital Management

Hambrecht & Quist Capital Management investment in Series A - Euthymics Bioscience

gbs-ventures_image

GBS Ventures

GBS Ventures investment in Series A - Euthymics Bioscience

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series A - Euthymics Bioscience

Official Site Inspections

http://www.euthymics.com

  • Host name: 104.21.43.153
  • IP address: 104.21.43.153
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Euthymics Bioscience"

Euthymics Bioscience Company Profile 2024: Valuation, …

Euthymics Bioscience is headquartered in Cambridge, MA. What is the size of Euthymics Bioscience? Euthymics Bioscience has 13 total employees. What industry is Euthymics Bioscience in? Euthymics Bioscience’s primary industry …See details»

Euthymics Bioscience, Inc. Company Profile - Dun & Bradstreet

Company Description: Euthymics Bioscience wants to put patients in a pleasant state of mind. Named for a medical term defined as a moderate mood that's neither manic nor depressed, …See details»

Organization | Euthymics BioScience, Inc.

Euthymics BioScience, Inc. Report issue For profit Phase 3 Founded: Cambridge MA United States (2009)See details»

Euthymics Bioscience Inc - Company Profile and News

Euthymics Bioscience, Inc. develops biopharmaceutical products. The Company offers products such as anti-depressant for major depressive disorder, as well as norepinephrine and dopamine.See details»

Euthymics - Overview, News & Similar companies | ZoomInfo.com

Euthymics is a company that operates in the Cosmetics industry. It employs 11-20 people and has $1M-$5M of revenue. The company is headquartered in Cambridge, Massachusetts. Read …See details»

Euthymics Bioscience - Products, Competitors, Financials, …

Euthymics Bioscience's latest funding round is Acquired. How much did Euthymics Bioscience raise? Euthymics Bioscience raised a total of $28.33M. Who are the investors of Euthymics …See details»

Euthymics Bioscience, Inc.: Contact Details and Business Profile

Euthymics Bioscience, Inc. is a Biotechnology, Neuropsychiatric drug development, and Pharmaceuticals company located in Cambridge, Massachusetts with 1 employees. Find top …See details»

Euthymics Bioscience - Funding, Financials, Valuation & Investors

Euthymics Bioscience is funded by 6 investors. GBS Ventures and H&Q Venture Capital are the most recent investors. Euthymics Bioscience has a post-money valuation in the range of …See details»

Euthymics Bioscience - Contacts, Employees, Board Members

Organization. Euthymics Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of …See details»

Euthymics Bioscience - VentureRadar

Euthymics’ management team is a group of experienced drug developers with a track record of success in neuroscience product development. We are dedicated to providing better …See details»

Euthymics Bioscience - Tech Company Profile - Gaebler.com …

Euthymics Bioscience is a leading biopharmaceutical company, located in Cambridge. Financial backing was provided by private investors, Novartis Venture Fund and Hambrecht & Quist …See details»

Euthymics’s Competitors, Revenue, Number of Employees ... - Owler

Euthymics’s Profile, Revenue and Employees. Euthymics Bioscience is a neuroscience-focused biopharmaceutical company that develops medicines for depressive disorders. Euthymics’s …See details»

Euthymics - Company Profile - Tracxn

Oct 21, 2024 Euthymics - Medicine for alcohol use disorder (AUD) and smoking cessation.. This company is not active anymore. Raised a total funding of $41.5M over 4 rounds from 6 …See details»

Business Profile for Euthymics Bioscience, Inc. - Better Business …

This organization is not BBB accredited. Pharmaceutical Research in Cambridge, MA. See BBB rating, reviews, complaints, & more.See details»

Euthymics Bioscience - Updates, News, Events, Signals & Triggers

Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders.See details»

ETHISMOS RESEARCH INC. CLOSES DEAL — Ethismos Research, Inc

Nov 1, 2017 Mr. McKinney has a strong background working with amitifadine since he was founding CEO of Euthymics starting in 2010. He also served as founding CEO of Neurovance …See details»

DOV-102677 - Drug Targets, Indications, Patents - Synapse

Dec 6, 2024 Background: Concurrent inhibitors of dopamine, norepinephrine, and serotonin uptake have been proposed as novel antidepressants. Given the high comorbidity between …See details»

Walter Piskorski - COO @ Euthymics Bioscience - Crunchbase

Walter Piskorski is the COO at Euthymics Bioscience. Additionally, Walter Piskorski has had 4 past jobs including COO at Neurovance. Euthymics Bioscience COO. Organization Name . …See details»

linkstock.net © 2022. All rights reserved